학술논문
A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients
Document Type
Article
Author
Source
In: Hematological Oncology . (Hematological Oncology, December 2022, 40(5):906-913)
Subject
Language
English
ISSN
10991069
02780232
02780232